Just hours after thousands of U.S. Food and Drug Administration employees were shown the door, Barclay Butler, the agency’s ...

Thousands of Food and Drug Administration employees are returning to the office to find overflowing parking lots, cramped ...

Here’s how it works: The patient sits in a chair by the five-foot-tall (about 1.5m) device, which is called Aletta, and ...

The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...

The FDA in recent years has aggressively moved to ... Those wanting to play Mega Millions now have to pay more for a ticket -- the next drawing in the multi-state lottery will cost $5, more ...

The FDA appealed that decision ... to your product" based on "a scientific rationale." Manufacturers could draw on "published literature reviews," although those are "considered a less robust ...

Alas, FDA makes no mention of other materials outside ... evaluated for proper risk and efficacy presentation. Readers can draw their own conclusions. In any case, the Letter counsels that each ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

packaging and shipping of investigational medicines and the factors that should be considered in drawing up a safety monitoring plan. The FDA first issued guidance on DCTs in 2020, out of ...